Published in Br J Clin Pharmacol on September 01, 2006
Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr (2010) 2.25
Practical therapeutic drug management in HIV-infected patients: use of population pharmacokinetic models supplemented by individualized Bayesian dose optimization. J Clin Pharmacol (2008) 1.30
Atazanavir pharmacokinetics with and without tenofovir during pregnancy. J Acquir Immune Defic Syndr (2011) 1.24
Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. HIV Clin Trials (2008) 1.22
Clinical therapeutics in pregnancy. J Biomed Biotechnol (2011) 1.08
Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women. Br J Clin Pharmacol (2008) 1.04
Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum. HIV Med (2008) 1.02
Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women. Antimicrob Agents Chemother (2009) 1.01
Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception. Antivir Ther (2010) 0.94
Pharmacokinetics of drugs in pregnancy. Semin Perinatol (2015) 0.94
Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation (2013) 0.91
Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics. HIV Med (2014) 0.86
Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit (2012) 0.86
Pharmacokinetic modelling of the placental transfer of nelfinavir and its M8 metabolite: a population study using 75 maternal-cord plasma samples. Br J Clin Pharmacol (2007) 0.84
Steady-state pharmacokinetics, cord blood concentrations, and safety of ritonavir-boosted fosamprenavir in pregnancy. J Acquir Immune Defic Syndr (2013) 0.83
Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review. PLoS Med (2016) 0.83
Implications of gender and pregnancy for antiretroviral drug dosing. Curr Opin HIV AIDS (2008) 0.80
Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals. Clin Pharmacokinet (2014) 0.80
Selection of HIV resistance associated with antiretroviral therapy initiated due to pregnancy and suspended postpartum. J Acquir Immune Defic Syndr (2011) 0.77
Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy. HIV AIDS (Auckl) (2009) 0.75
Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr (2002) 7.79
Pharmacokinetics of antiretrovirals in pregnant women. Clin Pharmacokinet (2004) 1.86
Practical guidelines to interpret plasma concentrations of antiretroviral drugs. Clin Pharmacokinet (2004) 1.82
Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet (1997) 1.80
Protein binding in antiretroviral therapies. AIDS Res Hum Retroviruses (2003) 1.67
Physiologic changes in pregnancy and their effect on drug disposition. Semin Perinatol (2001) 1.51
Drugs in pregnancy. Pharmacokinetics in pregnancy. Best Pract Res Clin Obstet Gynaecol (2001) 1.45
Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals. AIDS (2003) 1.41
HIV-infected pregnant women and vertical transmission in Europe since 1986. European collaborative study. AIDS (2001) 1.40
Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: structural identification, levels in plasma, and antiviral activities. Antimicrob Agents Chemother (2001) 1.37
Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother (2004) 1.35
The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum. Clin Pharmacol Ther (2004) 1.33
Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil. Eur J Clin Pharmacol (2003) 1.15
Transplacental passage of protease inhibitors at delivery. AIDS (2002) 1.12
Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women. AIDS (2003) 1.08
High-performance liquid chromatography of HIV protease inhibitors in human biological matrices. J Chromatogr B Biomed Sci Appl (2001) 1.06
Concentrations of protease inhibitors in cord blood after in utero exposure. Pediatr Infect Dis J (2002) 1.03
Increased 6-hydroxycortisol excretion in pregnant women: implication of drug-metabolizing enzyme induction. DICP (1990) 0.96
Clinical pharmacokinetics of nelfinavir and its metabolite M8 in human immunodeficiency virus (HIV)-positive and HIV-hepatitis C virus-coinfected subjects. Antimicrob Agents Chemother (2005) 0.96
Subtherapeutic antiretroviral plasma concentrations in routine clinical outpatient HIV care. Ther Drug Monit (2003) 0.93
Pharmacokinetics of indinavir in HIV-positive pregnant women. AIDS (2000) 0.89
Safety and pharmacokinetics of antiretroviral therapy during pregnancy. Ther Drug Monit (2004) 0.89
Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia. Lancet (1992) 1.81
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology (2011) 1.65
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV. HIV Med (2008) 1.54
Biodiversity of Pneumocystis carinii hominis: typing with different DNA regions. J Clin Microbiol (1997) 1.49
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011. BJOG (2013) 1.44
Characterization of surface layer proteins from different Clostridium difficile clinical isolates. Microb Pathog (2000) 1.23
Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. J Clin Microbiol (2001) 1.18
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues. Antimicrob Agents Chemother (2000) 1.18
Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women. J Infect Dis (2007) 1.16
Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome. J Infect Dis (1995) 1.16
Modulation of cell surface-associated mannoprotein antigen expression in experimental candidal vaginitis. Infect Immun (1994) 1.16
Rubella infection in pregnancy. Reprod Toxicol (2006) 1.15
Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas. Br J Cancer (2004) 1.13
Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients. AIDS (1995) 1.10
Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity. Antiviral Res (1996) 1.04
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect (2006) 1.04
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. AIDS (2001) 1.03
Ionizing radiations in pregnancy and teratogenesis: a review of literature. Reprod Toxicol (2005) 1.02
Variable efficiency of three primer pairs for the diagnosis of Pneumocystis carinii pneumonia by the polymerase chain reaction. Mol Cell Probes (1995) 1.01
Genetics, metabolism and host specificity of Pneumocystis carinii. Med Mycol (1998) 1.01
Saquinavir induces stable and functional expression of the multidrug transporter P-glycoprotein in human CD4 T-lymphoblastoid CEMrev cells. HIV Med (2003) 1.00
E-learning tools for education: regulatory aspects, current applications in radiology and future prospects. Radiol Med (2008) 0.99
Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. Biochem J (1999) 0.98
Haemopoietic CD34+ progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis. Br J Haematol (1993) 0.98
Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection. Eur J Clin Microbiol Infect Dis (2009) 0.97
1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cells. Biochim Biophys Acta (2001) 0.97
Saquinavir. Clinical pharmacology and efficacy. Clin Pharmacokinet (1998) 0.97
Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia. Int J Antimicrob Agents (2001) 0.96
Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol (1995) 0.96
Mitochondrial electron transport and glycolysis are coupled in articular cartilage. Osteoarthritis Cartilage (2012) 0.94
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Med (2012) 0.93
Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group. JAMA (1992) 0.93
Biophysical and structural characterization of 1H-NMR-detectable mobile lipid domains in NIH-3T3 fibroblasts. Biochim Biophys Acta (1999) 0.92
[Endosteal hyperostosis with recessive transmission (Van Buchem's disease). A case report]. Recenti Prog Med (1991) 0.91
Case of fatal encephalitis by HHV-6 variant A. J Med Virol (2001) 0.91
Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity. J Clin Invest (1995) 0.91
Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy. Epidemiol Infect (2006) 0.91
Intracellular localization of the antitumour drug adriamycin in living cultured cells: a confocal microscopy study. J Microsc (1994) 0.91
Human immunodeficiency virus and liver transplantation: our point of view. Transplant Proc (2008) 0.90
The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapy. HIV Med (2009) 0.89
Diminished interferon gamma production may be the earliest indicator of infection with the human immunodeficiency virus. Viral Immunol (1989) 0.88
Pregnancy outcomes and antiretroviral treatment in a national cohort of pregnant women with HIV: overall rates and differences according to nationality. BJOG (2007) 0.87
Congenital cystic adenomatoid malformation of the lung: antenatal ultrasound findings and fetal-neonatal outcome. Fifteen years of experience. Fetal Diagn Ther (2000) 0.87
Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study. Andrology (2015) 0.86
Influence of ofloxacin and pefloxacin on human lymphocyte immunoglobulin secretion and on polymorphonuclear leucocyte superoxide anion production. J Antimicrob Chemother (1988) 0.86
Long-term psychometric outcomes of facial lipoatrophy therapy: forty-eight-week observational, nonrandomized study. AIDS Patient Care STDS (2007) 0.86
Knowledge, attitudes and practice (KAP) regarding newborn feeding modalities in HIV-infected and HIV-uninfected pregnant women in sub-Saharan Africa: a multicentre study. Int Health (2011) 0.86
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. Leukemia (2005) 0.86
Hepatocellular carcinoma in HIV patients treated by liver transplantation. Eur J Surg Oncol (2007) 0.86
Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure. AIDS Res Hum Retroviruses (2008) 0.86
Familial incidence of precipitating antibodies in von Willebrand's disease: a study of four cases. J Lab Clin Med (1979) 0.86
Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study. Eur Neurol (1996) 0.85
Neuropsychological abnormalities in AIDS and asymptomatic HIV seropositive patients. J Neurol Neurosurg Psychiatry (1993) 0.85
Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. Transplant Proc (2007) 0.85
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.85
Inositol activity in oligoasthenoteratospermia--an in vitro study. Eur Rev Med Pharmacol Sci (2010) 0.85
Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen. HIV Med (2008) 0.85
Detection of P-glycoprotein in the nuclear envelope of multidrug resistant cells. Histochem J (2000) 0.84
Genetic variability in different Pneumocystis isolates from man and rats. New Microbiol (1995) 0.84
90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10(6) cells/L. Arch Pathol Lab Med (1998) 0.84
A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization. Bone Marrow Transplant (2006) 0.84
Interactions of anthracyclines with zwitterionic phospholipid monolayers at the air-water interface. Bioelectrochem Bioenerg (1999) 0.84
Sensitivity and specificity of a multi-antigen ELISA test for the serological diagnosis of tuberculosis. Int J Tuberc Lung Dis (1999) 0.83
A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma. Bone Marrow Transplant (2004) 0.83
Early complications in endovascular treatment of abdominal aortic aneurysm. Acta Chir Belg (2004) 0.83
Adriamycin-plasma membrane interaction in human erythrocytes. Eur J Cell Biol (1988) 0.83
Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy. AIDS Res Hum Retroviruses (1997) 0.82
University of Modena experience in HIV-positive patients undergoing liver transplantation. Transplant Proc (2011) 0.82
Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans. Infect Immun (1995) 0.82
AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987-93) and differential incidence according to mode of transmission of HIV-1 infection. J Neurol Sci (1996) 0.82
Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin. Br J Cancer (1997) 0.82
The effects of AZT and DDI on pre- and postimplantation mammalian embryos: an in vivo and in vitro study. AIDS Res Hum Retroviruses (1992) 0.82
High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. Bone (2004) 0.81
A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation. Transplant Proc (2005) 0.81
Immunohistochemical visualization of newly formed quinolinate in the normal and excitotoxically lesioned rat striatum. Exp Brain Res (2001) 0.81
A new model of pulmonary microembolism in the mouse. J Pharmacol Methods (1988) 0.81
Detection of Pneumocystis carinii in respiratory specimens by PCR-solution hybridization enzyme-linked immunoassay. J Clin Microbiol (1997) 0.81
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006). Infection (2007) 0.80
Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment. Antiviral Res (2000) 0.80
Very low frequence of Pneumocystis carinii DNA detection by PCR in specimens from patients with lung damage. J Clin Microbiol (2000) 0.80
Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of Quantiferon TB GOLD results in the transplant setting: a case report. Transplant Proc (2006) 0.80
Giant neutrophils with increased peroxidase activity. Another evidence of dysgranulopoiesis in AIDS. Am J Clin Pathol (1987) 0.80
Lack of selective V beta deletion in CD4+ or CD8+ T lymphocytes and functional integrity of T-cell repertoire during acute HIV syndrome. AIDS (1995) 0.80
Presumptive clinical criteria versus endoscopy in the diagnosis of Candida esophagitis at various HIV-1 disease stages. Endoscopy (1995) 0.80